Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/1997
03/06/1997WO1997007787A1 Oral cyclosporin formulations
03/06/1997WO1997007786A2 Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
03/06/1997WO1997007785A1 Therapeutic lipidic vesicles: methods of use and compositions
03/06/1997WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES
03/06/1997WO1997007783A1 Embolic material for endovascular occlusion of abnormal vasculature and method of using the same
03/06/1997WO1997007777A1 Peroxidase-activating oral compositions
03/06/1997WO1997007757A1 Bismuth-containing compounds in topical dosage forms
03/06/1997WO1997007685A1 Capsules containing freeze-dried powdered green tea leaves
03/06/1997WO1996039422A3 Modification of polypeptide drugs to increase electrotransport flux
03/06/1997WO1996039120A3 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
03/06/1997DE19532396A1 Zuckerfreie Produkte mit verbesserten Eigenschaften Sugar-free products with improved properties
03/06/1997CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
03/06/1997CA2230856A1 Methods and compositions for treating fungal infections in mammals
03/06/1997CA2230494A1 Composition for sustained release of an agent
03/06/1997CA2230238A1 Method for the production of pressed tablets containing live microorganisms and tablets produced by the method
03/06/1997CA2230094A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
03/06/1997CA2227278A1 Method and composition for enhanced parenteral nutrition
03/06/1997CA2202887A1 Oral cyclosporin formulations
03/05/1997EP0760366A1 Prostaglandin derivatives
03/05/1997EP0760240A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods
03/05/1997EP0760238A1 Percutaneously administrable preparation for treating urination disorder
03/05/1997EP0760237A1 Oil-in-water microemulsions
03/05/1997EP0760236A1 Deformable oil-based foam composition, containing a fluorated surfactant
03/05/1997EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
03/05/1997EP0759939A1 Methods and compositions for the dry powder formulation of interferons
03/05/1997EP0759784A1 Covalent microparticle-drug conjugates for biological targeting
03/05/1997EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness
03/05/1997EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS
03/05/1997EP0759773A1 Lacrimal gland specific emulsions for topical application to ocular tissue
03/05/1997EP0759768A1 Vasoactive intestinal polypeptide
03/05/1997EP0759757A1 Oral liquid alendronate formulations
03/05/1997EP0759756A1 Pharmaceutical composition for treating glaucoma containing terazosin
03/05/1997EP0759747A1 Transdermal device for administration through de-epithelialized skin
03/05/1997EP0759746A1 A medicated wipe
03/05/1997EP0759745A1 Method and composition for increasing calcium uptake
03/05/1997EP0759744A1 Narcotic containing aerosol formulation
03/05/1997EP0759743A1 Emulsion comprising a gelled aqueous outer phase, a non-aqueous intermediate phase and an aqueous inner phase
03/05/1997EP0759742A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
03/05/1997EP0759741A1 Mucoadhesive emulsions containing cyclodextrin
03/05/1997EP0759739A1 Improvements in dental floss
03/05/1997EP0759736A1 Liposome forming compositions
03/05/1997EP0759694A1 Method for in vivo delivery of therapeutic agents via liposomes
03/05/1997EP0705097B1 Incorporating poly-n-vinyl amide in a transdermal system
03/05/1997EP0618791B1 Solid complex particles comprising a biologically active solid substance, mode of preparation and compositions for topical use containing them and intended to treat biological surfaces
03/05/1997EP0597851B1 Method for preparing interferon alpha-2 crystals
03/05/1997EP0552151B1 Antimicrobial hydrogels
03/05/1997EP0550719B1 Neural implant system
03/05/1997EP0535068B1 Releasably bound active materials
03/05/1997EP0500885B1 Shaped articles as obtained from a thermoplastic starch melt
03/05/1997EP0491778B1 Apparatus for administering medicaments to mucosal tissue
03/05/1997CN2248562Y "Niao-bi-tong" plaster for urination
03/05/1997CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
03/05/1997CN1144481A Patch containing isosorbide dinitrate and prepared by using adhesive mixture
03/05/1997CN1144478A Bilayer preparations
03/05/1997CN1144477A Ophthalmic composition with decreased viscosity
03/05/1997CN1144476A Ophthalmic composition containing ion sensitive, hydrophilic polymer and inorganic salt in ratio which gives low viscosity
03/05/1997CN1144193A Medicinal water, method of production thereof, and dialysis apparatus using water as dialysis liquid
03/05/1997CN1144127A Bovine bezoar anti-inflammatory ointment
03/05/1997CN1144125A Xujinjiegu tablet for curing fracture
03/05/1997CN1144124A Sinew-soothing Network-Quickening Pill
03/05/1997CN1144122A Sarcandra glabra sugarless chewing gum
03/05/1997CN1144121A Chinese medicine composite for preventing dental caries
03/05/1997CN1144119A Medicine for curing hyperosteogeny
03/05/1997CN1144118A Yigankang capsule for curing hepatitis B
03/05/1997CN1144117A Yigan medical capsule for curing hepatitis B
03/05/1997CN1144116A Yigankang Chinese medicine capsule for curing hepatitis B
03/05/1997CN1144115A Gantai tablet for curing hepatic disease
03/05/1997CN1144114A Sanzhufuzheng anticancer oral liquor and preparation method thereof
03/05/1997CN1144113A Medicine for curing throat disease and its preparation method
03/05/1997CN1144111A Shuangjie Jiangtangjing capsule
03/05/1997CN1144110A Pure traditional Chinese medicine antipyretic plaster for baby and its preparation technology thereof
03/05/1997CN1144108A Yatongsan powder for curing toothache
03/05/1997CN1144107A Cuyunyifuling plaster
03/05/1997CN1144106A Health-care oral liquor for preventing cold and raising immunity
03/05/1997CN1144105A Licorice root ointment and producing process thereof
03/05/1997CN1144101A Antifebrile oral liquor
03/05/1997CN1144094A Membrane agent drug made of sodium fulvate and/or berberine for curing gynecopathy
03/05/1997CN1144093A Iron-cobalt-selenium mixture
03/05/1997CN1144088A Colading sticking sheet and nicotine sticking sheet compound smoking stopping method
03/05/1997CN1144087A Medicine release control type percutaneous absorber
03/05/1997CN1144086A Biological skeleton, biological skeleton-membrane medicine-feeding system
03/05/1997CA2184654A1 Method of production of sustained-release preparation
03/04/1997US5608052 Enzyme inhibitors of beta-lactamase
03/04/1997US5608038 Highly concentrated immunoglobulin preparation and method for its production
03/04/1997US5607940 Drug delivery for narcotic analgesics
03/04/1997US5607921 Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof
03/04/1997US5607915 Pulmonary delivery of active fragments of parathyroid hormone
03/04/1997US5607721 Hot-melt silicone pressure sensitive adhesive with siloxylated polyether waxes as additives
03/04/1997US5607707 Optically clear products for use in human and animal healthcare
03/04/1997US5607698 Method of preserving ophthalmic solution and compositions therefor
03/04/1997US5607697 Taste masking microparticles for oral dosage forms
03/04/1997US5607696 Cellulose acetate butyrate
03/04/1997US5607695 Process for the manufacture of porous cellulose matrices
03/04/1997US5607694 Forming sealant by mixing virus inactivated fibrinogen and thrombin, liposomes with entrapped medicaments deliverable in wound or opening, and calcium; thrombin promotes fibrin clot formation, liposomes release medicaments
03/04/1997US5607692 Mixture of two lipid vesicle dispersions: first for deep layer treatment has anti- or de-pigmenting agent or tyrosinase inhibitor; second for surface layer treatment has keratolytic, moisturizing or protective agent
03/04/1997US5607691 Compositions and methods for enhanced drug delivery
03/04/1997US5607690 Diclofenac, hydroxyethyl-pyrroldine or piperidine
03/04/1997US5607687 Polymer blends containing absorbable polyoxaesters
03/04/1997US5607685 Protracted-release adminstration forms containing clindamycin palmitate
03/04/1997US5607677 Glucan drug delivery system and adjuvant